Fluticasone propionate and Atrioventricular block second degree - a phase IV clinical study of FDA data

Summary:

Atrioventricular block second degree is reported as a side effect among people who take Fluticasone propionate (fluticasone propionate), especially for people who are female, 60+ old, also take Diltiazem Hydrochloride, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Atrioventricular block second degree when taking Fluticasone propionate. It is created by eHealthMe based on reports of 33,984 people who have side effects when taking Fluticasone propionate from the FDA, and is updated regularly.

What is Fluticasone propionate?

Fluticasone propionate has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 35,174 Fluticasone propionate users. Check the latest studies of Fluticasone propionate.

What is Atrioventricular block second degree?

Atrioventricular block second degree (heart block second degree) is found to be associated with 377 drugs and 818 conditions by eHealthMe. Check the latest studies of Atrioventricular block second degree.

On Jul, 13, 2026

33,984 people reported to have side effects when taking Fluticasone propionate.
Among them, 14 people (0.04%) have Atrioventricular block second degree.

Could Fluticasone propionate cause Atrioventricular block second degree?

Among these 14 people:

What is the gender of people who have Atrioventricular block second degree when taking Fluticasone propionate? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Atrioventricular block second degree when taking Fluticasone propionate? *

What are other drugs people take besides Fluticasone propionate? *

Hydrocodone Bitartrate And Acetaminophen: 3 people, 21.43%
Revlimid: 3 people, 21.43%
Furosemide: 3 people, 21.43%
Gabapentin: 3 people, 21.43%
Digoxin: 3 people, 21.43%
Isosorbide Mononitrate: 3 people, 21.43%
Lisinopril: 3 people, 21.43%
Clonazepam: 3 people, 21.43%
Moduretic 5-50: 3 people, 21.43%
Diltiazem Hydrochloride: 3 people, 21.43%

What are other side effects people have besides Atrioventricular block second degree? *

Confusion: 4 people, 28.57%
Ventricular Extrasystoles (premature cardiac contraction): 3 people, 21.43%
Bundle Branch Block Left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle): 3 people, 21.43%
Confusional State: 3 people, 21.43%
Hyperkalemia (damage to or disease of the kidney): 3 people, 21.43%
Speech Impairment (Adult) (inability to speak (adult)): 3 people, 21.43%
Arrhythmias (irregular heartbeat): 3 people, 21.43%
Atrioventricular Block First Degree (heart block first degree): 3 people, 21.43%
Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 3 people, 21.43%
Essential Hypertension (primary hypertension): 2 people, 14.29%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 14.29%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 14.29%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 7.14%
Ovarian Cancer (cancer of ovary): 1 person, 7.14%
Nausea (feeling of having an urge to vomit): 1 person, 7.14%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Depression: 1 person, 7.14%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Fluticasone propionate and have Atrioventricular block second degree?

- Check whether Atrioventricular block second degree is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fluticasone propionate:

Fluticasone propionate (35,174 reports)

Browse all side effects of Fluticasone propionate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrioventricular block second degree:

Atrioventricular block second degree (377 drugs)

Browse all the conditions that are associated with Atrioventricular block second degree:

Atrioventricular block second degree (818 conditions)

Related publications that referenced our studies

Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate (the active ingredients of Fluticasone propionate) and Fluticasone propionate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.